TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36244640

Group type: COMPARATOR
Intervention: Control group of a trial of medication adherence reminder and symptom self-management intervention
Number of subjects: 117
Study: 34406392

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency group (n = 1190)
Number of subjects: 1887

Group type: COMPARATOR
Intervention: Vitamin D sufficiency group (n = 686)
Number of subjects: 1887

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 1887
Study: 32232410

Group type: EXPERIMENTAL
Intervention: NP213 (Novexatin®) applied daily for 28 days
Number of subjects: 0
Study: 35279112

Group type: EXPERIMENTAL
Intervention: Opicapone (OPC) 50 mg once daily
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 33504329

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 110
Study: 616120954

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IAI) 2mg every 4 weeks (2q4)
Number of subjects: 2457

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5mg every 4 weeks (Rq4)
Number of subjects: 2457

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IAI) 2mg every 8 weeks (2q8)
Number of subjects: 2457
Study: 34117549

Group type: EXPERIMENTAL
Intervention: Improved cook stoves
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional cook stoves
Number of subjects: 0
Study: 35139410

Group type: EXPERIMENTAL
Intervention: HAF Toothpaste (1000 and 1450 ppmF)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: HAF Toothpaste (1450 ppmF)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Traditional Fluoridated Toothpaste
Number of subjects: 610
Study: 33921105

Group type: EXPERIMENTAL
Intervention: Feel‐Breathe device (FBG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oronasal breathing without FB (ONBG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study: 33066233

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) therapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FMT
Number of subjects: 16
Study: 34551678

Group type: EXPERIMENTAL
Intervention: TDF/FTC + RAL (400 mg b.d.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TDF/FTC + DTG
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TDF/FTC + EVG/c
Number of subjects: 60
Study: 32049269

Group type: EXPERIMENTAL
Intervention: Permissive hypotension (MAP target 60-65 mm Hg)
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Usual care (vasopressors at the discretion of treating clinicians)
Number of subjects: 2463
Study: 35858181

Group type: EXPERIMENTAL
Intervention: S-CHOP (Ripertamab combined with CHOP)
Number of subjects: 364

Group type: COMPARATOR
Intervention: R-CHOP (Rituximab combined with CHOP)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: S-CHOP
Number of subjects: 364

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 364
Study: 34159380

Group type: EXPERIMENTAL
Intervention: Nsp2-interacting proteins identified through affinity purification mass spectrometry (AP-MS) and stable isotope labeling by amino acids in cell culture (SILAC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nsp2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bio-layer interferometry (BLI) assay
Number of subjects: 0
Study: 35032700

Group type: EXPERIMENTAL
Intervention: Affect Management Treatment (AMT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 52
Study: 32200433

Group type: EXPERIMENTAL
Intervention: Olfaction rehabilitation (OPRAT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study: 34383632

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 45
Study: 33980690

Group type: EXPERIMENTAL
Intervention: Target LDL cholesterol of <70 mg/dL
Number of subjects: 2860

Group type: COMPARATOR
Intervention: Target LDL cholesterol of 100 ± 10 mg/dL
Number of subjects: 2860

Group type: EXPERIMENTAL
Intervention: Target LDL cholesterol of <70 mg/dL (in patients with diabetes)
Number of subjects: 2860

Group type: COMPARATOR
Intervention: Target LDL cholesterol of 100 ± 10 mg/dL (in patients with diabetes)
Number of subjects: 2860

Group type: EXPERIMENTAL
Intervention: Target LDL cholesterol of <70 mg/dL (newly diagnosed diabetes)
Number of subjects: 2860

Group type: COMPARATOR
Intervention: Target LDL cholesterol of 100 ± 10 mg/dL (newly diagnosed diabetes)
Number of subjects: 2860
Study: 32867047

Group type: EXPERIMENTAL
Intervention: 29 mL of vinegar and 451 mL of water
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 39 g of sucrose and 441 mL of water
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 29 mL of vinegar and 39 g of sucrose and 412 mL of water
Number of subjects: 22

Group type: COMPARATOR
Intervention: 480 mL of water alone
Number of subjects: 22
Study: 34713704

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 192

Group type: COMPARATOR
Intervention: Milrinone
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: AMICS
Number of subjects: 192

Group type: COMPARATOR
Intervention: Non-AMICS
Number of subjects: 192
Study: 33279104

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) at 10 Hz for 45 minutes followed by 30 minutes of aerobic exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo TENS followed by 30 minutes of aerobic exercise
Number of subjects: 8
Study: 34023514

Group type: EXPERIMENTAL
Intervention: Spiral thread sutures
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional sutures (0-Vicryl)
Number of subjects: 200
Study: 35611970

Group type: EXPERIMENTAL
Intervention: Afirma GSC (suspicious result)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Afirma GSC (benign result)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: ThyroSeq v3 (positive result)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: ThyroSeq v3 (negative result)
Number of subjects: 343
Study: 32581204

Group type: EXPERIMENTAL
Intervention: 20 mg of esomeprazole twice daily (BD)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 40 mg of esomeprazole once daily (OD)
Number of subjects: 37
Study: 36209520

Group type: EXPERIMENTAL
Intervention: High explicit language
Number of subjects: 498

Group type: COMPARATOR
Intervention: Low explicit language
Number of subjects: 498
Study: 34113957

Group type: EXPERIMENTAL
Intervention: EPA-rich oil (360 mg DHA/d and 900 mg EPA/d)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: DHA-rich oil (900 mg DHA/d and 270 mg EPA/d)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo (3000 mg/d refined olive oil)
Number of subjects: 310
Study: 34323290

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (225 mg at baseline, week 4, and week 8)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg at baseline, placebo at weeks 4 and 8)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study: 32930088

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) delivered via 13 out-patient sessions over 160 days
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Person-Centred Experiential Therapy (PCE) delivered via six out-patient sessions over 63 days
Number of subjects: 1

Group type: COMPARATOR
Intervention: Baseline assessment phase (A; 28 days; three sessions)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Follow-up period (99 days)
Number of subjects: 1
Study: 35233755

Group type: EXPERIMENTAL
Intervention: Trastuzumab + chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab + chemotherapy vs trastuzumab monotherapy
Number of subjects: 0
Study: 33385220

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study: 33577365

Group type: EXPERIMENTAL
Intervention: Long-term androgen deprivation therapy (LT-ADT) with calcium and vitamin D supplementation (CalVitD) (500 mg of Calcium BID + 400 IU of Vitamin D3 BID)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (CalVitD)
Number of subjects: 230
Study: 35369896

Group type: EXPERIMENTAL
Intervention: Food-based nutrition counselling and education intervention
Number of subjects: 10
Study: 35111703

Group type: EXPERIMENTAL
Intervention: PHiD‐CV (single dose)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 292
Study: 33008770

Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg/day)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control
Number of subjects: 424
Study: 35291434

Group type: EXPERIMENTAL
Intervention: Intravenous caffeine (10 mg/Kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous normal saline (placebo)
Number of subjects: 18
Study: 36164137

Group type: EXPERIMENTAL
Intervention: Isa-Kd (Isatuximab 10 mg/kg IV weekly for 4 weeks, then every 2 weeks; Carfilzomib 20/56 mg/m2 twice weekly, 3/4 weeks)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Isa-Kd
Number of subjects: 302
Study: 34047291

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 810 nm, 200 MW constant power, 30s irradiation time, energy dose of 6 J
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham laser treatment
Number of subjects: 20
Study: 34695227

Group type: EXPERIMENTAL
Intervention: Vaccinated individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previously infected individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall population seroprevalence
Number of subjects: 0
Study: 33642694

Group type: EXPERIMENTAL
Intervention: Hybrid assistive limb treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 20
Study: 32800792

Group type: EXPERIMENTAL
Intervention: Football Fitness group (FFG, n = 46)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (CON, n = 22)
Number of subjects: 68
Study: 33971037

Group type: EXPERIMENTAL
Intervention: Elobixibat plus 1-L PEG-Asc solution (group A)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sodium picosulfate plus 1-L PEG-Asc solution (group B)
Number of subjects: 210
Study: 32776853

Group type: EXPERIMENTAL
Intervention: Protocolized sedation management (intervention arm)
Number of subjects: 2271

Group type: COMPARATOR
Intervention: Usual care (control arm)
Number of subjects: 2271
Study: 616037868

Group type: EXPERIMENTAL
Intervention: B&L Akreos AO60
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AMO Tecnis ZCB00
Number of subjects: 20
Study: 35238311

Group type: EXPERIMENTAL
Intervention: Levosimendan preconditioning
Number of subjects: 258

Group type: COMPARATOR
Intervention: Dobutamine (Control)
Number of subjects: 258
Study: 35700157

Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33979752

Group type: EXPERIMENTAL
Intervention: FreeStyle Navigator II subcutaneous CGM system from Abbott
Number of subjects: 94
Study: 33036588

Group type: EXPERIMENTAL
Intervention: Hydrocortisone dose A (20 mg/10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hydrocortisone dose C (10 mg/5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Night-time serum cortisone levels
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Total urinary cortisol metabolites
Number of subjects: 10
Study: 35803549

Group type: EXPERIMENTAL
Intervention: Opioid-sparing (OS) postoperative pain protocol
Number of subjects: 78

Group type: COMPARATOR
Intervention: Traditional opioid-based (OB) postoperative pain protocol
Number of subjects: 78
Study: 33819072

Group type: COMPARATOR
Intervention: Oxycodone (5 mg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ketorolac (10 mg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 83103622

Group type: EXPERIMENTAL
Intervention: Psoradrate (0.1% dithranol with 17% urea)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dithrocream (0.25% dithranol in vanishing cream)
Number of subjects: 40
Study: 35164859

Group type: COMPARATOR
Intervention: Model-oriented group (n = 10)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Differential Learning group (n = 11)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 36
Study: 33359250

Group type: EXPERIMENTAL
Intervention: Osteoarthritis
Number of subjects: 258696

Group type: COMPARATOR
Intervention: No osteoarthritis (Control)
Number of subjects: 258696
Study: 35178150

Group type: EXPERIMENTAL
Intervention: Water treatment (household chlorination with sodium hypochlorite)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Handwashing (with soap)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined intervention (water treatment and handwashing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (customary practices)
Number of subjects: 0
Study: 32560898

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36471204

Group type: EXPERIMENTAL
Intervention: BGS-7 spacer
Number of subjects: 54

Group type: COMPARATOR
Intervention: PEEK cage
Number of subjects: 54
Study: 34225380

Group type: EXPERIMENTAL
Intervention: Tubeless technique
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 63
Study: 34719064

Group type: EXPERIMENTAL
Intervention: Personalized visual triggers during fMRI scans
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subject-specific trigger images
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MRI methodology specific for urologic use
Number of subjects: 10
Study: 33475184

Group type: EXPERIMENTAL
Intervention: C. zeylanicum (0.5 mg/mL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nystatin (100,000 IU/mL)
Number of subjects: 36
Study: 32151146

Group type: EXPERIMENTAL
Intervention: DriSti intervention (partly tablet-administered, interactive)
Number of subjects: 3182
Study: 35134317

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Uterine artery embolization (UAE)
Number of subjects: 34
Study: 32892392

Group type: EXPERIMENTAL
Intervention: Single-layer uterine closure
Number of subjects: 2292

Group type: EXPERIMENTAL
Intervention: Double-layer uterine closure
Number of subjects: 2292
Study: 35555498

Group type: EXPERIMENTAL
Intervention: 3D brachial plexus board model
Number of subjects: 12

Group type: COMPARATOR
Intervention: Drawing the brachial plexus utilizing the online resource, Draw It to Know It
Number of subjects: 12
Study: 32139102

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT) with irrigation at 30 cc per hour
Number of subjects: 150

Group type: COMPARATOR
Intervention: Negative Pressure Wound Therapy (NPWT) without irrigation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT) with irrigation
Number of subjects: 150
Study: 35501772

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) program
Number of subjects: 91

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 91
Study: 32664809

Group type: EXPERIMENTAL
Intervention: Patient-centered multi-component hospital-to-home (H2H) program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Guideline-based asthma care without H2H program
Number of subjects: 32
Study: 35046704

Group type: EXPERIMENTAL
Intervention: Aggressive temperature management (Group A)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Routine temperature management (Group C)
Number of subjects: 98
Study: 34814933

Group type: EXPERIMENTAL
Intervention: Tenofovir/lamivudine (TDF/3TC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tenofovir/lamivudine (TDF/3TC) plus atazanavir/ritonavir (ATV/r)
Number of subjects: 24
Study: 32425006

Group type: EXPERIMENTAL
Intervention: Internet-based integrated intervention
Number of subjects: 0
Study: 35470916

Group type: EXPERIMENTAL
Intervention: Crocin (15 mg, twice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33394881

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (18 sessions)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual activity control
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 83
Study: 34009900

Group type: EXPERIMENTAL
Intervention: Video-guided assistance (U-V, T-V)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Telephone-guided assistance (U-T, T-T)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Trained telephone-guided (T-T)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Video-guided (T-V)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Untrained video-guided (U-V)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Untrained telephone-guided (U-T)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Trained video-guided (T-V)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Video groups (U-V, T-V)
Number of subjects: 120
Study: 33930401

Group type: EXPERIMENTAL
Intervention: Full CIC membrane GC count using cell-counting software
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Partial membrane GC count using cell-counting software
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Manual counting of the 25 images
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Comparison of GCD values between full and manual methods
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Comparison of GCD values between full and partial methods
Number of subjects: 32

Group type: COMPARATOR
Intervention: Storage duration (2–3 weeks vs 6–7 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Storage container types (microcentrifuge tube vs flat histology cassette)
Number of subjects: 32
Study: 36000550

Group type: EXPERIMENTAL
Intervention: Accumed NF60 nebulizer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Allegro nebulizer
Number of subjects: 32
Study: 32013681

Group type: EXPERIMENTAL
Intervention: Sodium control during post-dilution online hemodiafiltration treatments
Number of subjects: 81

Group type: COMPARATOR
Intervention: Isolated ultrafiltration for the first 90 minutes followed by sodium control during post-dilution online hemodiafiltration
Number of subjects: 81
Study: 36463355

Group type: EXPERIMENTAL
Intervention: Specialist palliative care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33838536

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block with local anesthetic (10 mL of 1% lidocaine + 10 mL of 0.5% bupivacaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block
Number of subjects: 50
Study: 34319670

Group type: EXPERIMENTAL
Intervention: Mini‐Five Gracey Curettes (MFC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional Gracey Curettes (CGC)
Number of subjects: 20
Study: 35611492

Group type: EXPERIMENTAL
Intervention: Neurofeedback-based neuropsychotherapy (20-hour combined computerized training program)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control group (CON)
Number of subjects: 50
Study: 33757158

Group type: EXPERIMENTAL
Intervention: Fronto-parieto-occipital tACS (alpha-frequency in-phase)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fronto-parieto-occipital tACS (alpha-frequency antiphase)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fronto-parieto-occipital tACS (gamma frequency antiphase control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: tACS responders
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study: 32556001

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention plus treatment as usual
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 42
Study: 35426173

Group type: EXPERIMENTAL
Intervention: UB-312 (300/300/300 μg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33982590

Group type: EXPERIMENTAL
Intervention: NMES‐RT
Number of subjects: 33

Group type: COMPARATOR
Intervention: PMT
Number of subjects: 33
Study: 32506371

Group type: EXPERIMENTAL
Intervention: Minocycline 400 mg orally twice a day with bevacizumab 10 mg/kg IV every two weeks and reirradiation
Number of subjects: 10
Study: 34649960

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including brief telephone and print education, delivered in multiple languages, and personalized referral to a low-cost/free vaccine provider
Number of subjects: 238

Group type: COMPARATOR
Intervention: Routine practice (Control)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 238
Study: 33908377

Group type: EXPERIMENTAL
Intervention: Stimulant diversion prevention intervention
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Treatment disclosure
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Tolerance for stimulant misuse and diversion
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Peer norms favorable to stimulant misuse and diversion
Number of subjects: 341
Study: 35933897

Group type: EXPERIMENTAL
Intervention: 250 mg shilajit extract
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 500 mg shilajit extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35900838

Group type: EXPERIMENTAL
Intervention: Patiromer
Number of subjects: 878

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 878
Study: 32717289

Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 32293045

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined CO2 and Nd:YAG lasers
Number of subjects: 30

Group type: COMPARATOR
Intervention: All treatment modalities
Number of subjects: 30
Study: 34353615

Group type: EXPERIMENTAL
Intervention: Olaparib 300 mg twice daily
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391